Here are 11 key notes on orthopedic and spine device companies over the past week.
Spinal Tech
Exactech performed the first successful revisionary knee procedure with its guided personalized surgery system. Here's what you need to know.
Zacks Investment Research lowered its rating of Entellus Medical from "buy" to "hold" on Oct. 5, BBNS reports.
Lyon, France-based Medicrea reported its sales results for the third quarter of 2016, ending Sept. 30.
St. Jude Medical receives FDA approval, announces 1st implant of Infinity DBS system: 5 observations
St. Paul, Minn.-based St. Jude Medical received FDA approval for the St. Jude Medical Infinity Deep Brain Stimulation system and its DBS directional lead.
The FDA cleared K2M's CASCADIA Lateral Interbody System line expansion.
Belgrade, Mont.-based Xtant Medical named Carl O'Connell its new president, effective Oct. 6.
Benvenue Medical announced clinical data presentations for its Luna 3D Multi-Expandable Interbody Fusion System and Kiva VCF Treatment System at the Society of Minimally Invasive Spine Surgery Annual Forum '16 from Oct. 13 to Oct. 15 in Las Vegas.
An HSS Inspector report found Medicare spent nearly $1.5 billion on seven types of defective heart devices, according to Star Tribune.
The Albany, N.Y.-based practice Capital Regional Orthopaedic Associates has performed New York state's first meniscus replacement using the investigational NUsurface Meniscus Implant.
